A cross-border investigation examines how intellectual property and drug pricing transformed a life-saving medicine into a highly profitable global commodity. The report highlights the significant struggle many patients face accessing the medication.

A cross-border investigation by DW and ICIJ reveals how pricing and patents helped turn a life-saving medicine into one of the world's best selling drugs while leaving many patients struggling to access it.